[1. Aoki T, Tsuchida M, Watanabe T, Hashimoto T, Koike T, Hirono T, Hayashi J. Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians. // Eur J Cardiothorac Surg, 2003; 23(4):446-450.10.1016/S1010-7940(03)00014-9]Search in Google Scholar
[2. Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. // Biomark Med, 2013; 7(1):49-58.10.2217/bmm.12.111]Search in Google Scholar
[3. Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, Kondo T. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymphnode dissection. // Interact CardioVasc Thorac Surg, 2009; 8(1):89-92.10.1510/icvts.2008.193383]Search in Google Scholar
[4. Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, Grimaillof-Junior A, Cesar-Lopez G, Milanez-de- Campos JR, Riquet MR, Biscegli-Jatene F. Fasttrack rehabilitation for lung cancer lobectomy: a five-year experience. // Eur J Cardiothorac Surg, 2009; 36(2):383-392.10.1016/j.ejcts.2009.02.020]Search in Google Scholar
[5. Gao WM, Kuick R, Orchekowski RP, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. // BMC Cancer, 2005; 5:110.10.1186/1471-2407-5-110]Search in Google Scholar
[6. Giovannetti R, Alifano M, Stefani A, Legras A, Grigoroiu M, Collet JY, Magdelenat P, Regnard JF. Surgical treatment of bronchiectasis: early and long-term results. // Interact CardioVasc Thorac Surg, 2008; 7(4):609-612.10.1510/icvts.2007.163972]Search in Google Scholar
[7. Ferguson MK, Celauro AD, Vigneswaran WT. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. // Eur J Cardiothorac Surg, 2012; 41(3):598-602.10.1093/ejcts/ezr081]Search in Google Scholar
[8. Ferguson MK and Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. // Eur J Cardiothorac Surg, 2003; 23(1):35-42.10.1016/S1010-7940(02)00675-9]Search in Google Scholar
[9. Khan N, Cromer CJ, Campa M, et al. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. // Cancer, 2004; 101:379-384.10.1002/cncr.2037715241837]Search in Google Scholar
[10. Kojima F, Yamamoto K, Matsuoka K, Ueda M, Hamada H, Imanishi N, Miyamoto Y. Factors affecting survival after lobectomy with pulmonary artery resection for primary lung cancer. // Eur J Cardiothorac Surg, 2011; 40(1):13-20.10.1016/j.ejcts.2011.02.02621435895]Search in Google Scholar
[11. Kouritas VK, Zissis C and Bellenis I. Variation of the postoperative fluid drainage according to the type of lobectomy. // Interact CardioVasc Thorac Surg, 2013; 16(4):437-440.10.1093/icvts/ivs529]Search in Google Scholar
[12. López E, Cho WC. Phosphoproteomics and lung cancer research. // Int J Mol Sci, 2012; 13(10):12287-314.10.3390/ijms131012287]Search in Google Scholar
[13. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. // Eur J Cardiothorac Surg, 2005; 28(3):380-383.10.1016/j.ejcts.2005.06.010]Search in Google Scholar
[14. Paesmans M. Prognostic and predictive factors for lung cancer. Review. // Eur Respir J Breathe, 2012; 9:113 - 122.]Search in Google Scholar
[15. Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Romero-Romero B, Mediano MD, López-Campos JL, García-Carbonero R, Sanchez-Gastaldo A, Carnero A, Paz-Ares L. Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. // Int J Mol Sci, 2013; 14(2):3440-55.10.3390/ijms14023440]Search in Google Scholar
[16. Patz EF Jr, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer. // J Clin Oncol, 2007; 25:5578-5583.10.1200/JCO.2007.13.5392]Search in Google Scholar
[17. Sakuragi T, Sakao Y, Furukawa K, Rikitake K, Ohtsubo S, Okazaki Y, Natsuaki M, Itoh T. Successful management of acute pulmonary embolism after surgery for lung cancer. // Eur J Cardiothorac Surg, 2003; 24(4):580-587.10.1016/S1010-7940(03)00392-0]Search in Google Scholar
[18. Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M. Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery. // Eur J Cardiothorac Surg, 2007; 31(4):719-724.10.1016/j.ejcts.2007.01.02717317198]Search in Google Scholar
[19. Taenzer A, Alix-Panabières C, Wikman H, Pantel K. Circulating tumor-d erived biomarkers in lung cancer. // J Thorac Dis, 2012; 4(5):448-9.]Search in Google Scholar
[20. Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P, Ying K. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. // Cancer Biomark, 2012; 11(4):129-37. 10.3233/CBM-2012-0027023144150]Search in Google Scholar